Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam for sedation and analgesia during distal radius fracture reduction in the emergency department
IRCT20160401027165N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexmedetomidine, midazolam and fentanyl in distal forearm fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pain severity, Blood pressure and 8 more. Started Apr 2014; status: completed.
02
Drugs
dexmedetomidinemidazolamfentanyl
03
Conditions
distal forearm fracture
Beyond the preview
Go deeper on IRCT20160401027165N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160401027165N1.